INTERNATIONAL ORTHOPAEDICS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=854014, encodeId=5dcc8540144c, content=该期刊要求的参考文献格式是endnote中的那种格式形式？？？？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Sat Sep 28 20:17:08 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201158, encodeId=f44c120115812, content=杂志让我大修，但是我没有看到审稿人的意见，请问在哪里可以找到审稿人的意见。谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9535709916, createdName=ms4000000490604277, createdTime=Thu Mar 10 09:26:53 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092120, encodeId=20af109212061, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558103, encodeId=21b25581031e, content=4月27日submit 6月3日minor revision 6月19日final decision accept 挺快的，哪位老师知道，我什么时候才能收到proof的连接？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OUyyGOPy0mM0ibLLxiccOYeFdnmeZ4e2wHZzhia9yQGb1NalRFoQdokXjW9EOd5EEKyBxDibrfOgmA6uibTvE937MPA/132, createdBy=9c5c1768279, createdName=老时, createdTime=Tue Jun 19 19:21:00 CST 2018, time=2018-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555066, encodeId=a3155550668c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：D+0 new submission, D+2 editor assigned, D+32 revise before review(要求加2 reference), D+32 revision submission, D+36 reviewers assigned, D+38 under review, D+43 reviewers assigned, D+45 reviewers assigned , D+76 直接accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92ec2265994, createdName=Midaniel, createdTime=Mon Apr 16 21:49:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601798, encodeId=ea04601e9857, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿到一审结束一个月，大修后录用，对创新性要求比较高，最好对临床有一定指导意义的文章容易录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b78f1736747, createdName=南方一刀, createdTime=Mon Jun 08 13:24:15 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092119, encodeId=34a3109211961, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965334, encodeId=549296533478, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨科临床研究 ; 骨科 经验分享：投稿半个月，目前已经接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e165222307, createdName=147818b7m56暂无昵称, createdTime=Thu May 13 21:30:24 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801061, encodeId=493180106181, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：sicot的官方杂志，2019的if也是猛涨，但是命中率狠低，但是审稿速度很快，可以尝试!<a href='/topic/show?id=3b1484506af' target=_blank style='color:#2F92EE;'>#脊柱#</a>但是对脊柱的文章需求量很少，真的真的太难中了，投了腰椎的和meta各一篇，都因为栏目不合适被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=5, topicName=null, topicId=null, topicList=[TopicDto(id=84506, encryptionId=3b1484506af, topicName=脊柱)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/ffbd7ae7f19a46d4bc76eadb164c5760/b3d082253d45492c9aa02bec640eb0af.jpg, createdBy=52185311019, createdName=drbob, createdTime=Fri Jul 03 11:54:53 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947860, encodeId=624594e86084, content=骨科专科杂志，最新IF=2.854，收录范围：骨科、康复、整形外科、运动医学、骨科临床手术或与骨科相关的基础研究等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sat Mar 13 14:39:53 CST 2021, time=2021-03-13, status=1, ipAttribution=)]

2019-09-28 ms9495958415321966

该期刊要求的参考文献格式是endnote中的那种格式形式？？？？

133 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=854014, encodeId=5dcc8540144c, content=该期刊要求的参考文献格式是endnote中的那种格式形式？？？？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Sat Sep 28 20:17:08 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201158, encodeId=f44c120115812, content=杂志让我大修，但是我没有看到审稿人的意见，请问在哪里可以找到审稿人的意见。谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9535709916, createdName=ms4000000490604277, createdTime=Thu Mar 10 09:26:53 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092120, encodeId=20af109212061, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558103, encodeId=21b25581031e, content=4月27日submit 6月3日minor revision 6月19日final decision accept 挺快的，哪位老师知道，我什么时候才能收到proof的连接？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OUyyGOPy0mM0ibLLxiccOYeFdnmeZ4e2wHZzhia9yQGb1NalRFoQdokXjW9EOd5EEKyBxDibrfOgmA6uibTvE937MPA/132, createdBy=9c5c1768279, createdName=老时, createdTime=Tue Jun 19 19:21:00 CST 2018, time=2018-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555066, encodeId=a3155550668c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：D+0 new submission, D+2 editor assigned, D+32 revise before review(要求加2 reference), D+32 revision submission, D+36 reviewers assigned, D+38 under review, D+43 reviewers assigned, D+45 reviewers assigned , D+76 直接accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92ec2265994, createdName=Midaniel, createdTime=Mon Apr 16 21:49:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601798, encodeId=ea04601e9857, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿到一审结束一个月，大修后录用，对创新性要求比较高，最好对临床有一定指导意义的文章容易录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b78f1736747, createdName=南方一刀, createdTime=Mon Jun 08 13:24:15 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092119, encodeId=34a3109211961, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965334, encodeId=549296533478, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨科临床研究 ; 骨科 经验分享：投稿半个月，目前已经接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e165222307, createdName=147818b7m56暂无昵称, createdTime=Thu May 13 21:30:24 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801061, encodeId=493180106181, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：sicot的官方杂志，2019的if也是猛涨，但是命中率狠低，但是审稿速度很快，可以尝试!<a href='/topic/show?id=3b1484506af' target=_blank style='color:#2F92EE;'>#脊柱#</a>但是对脊柱的文章需求量很少，真的真的太难中了，投了腰椎的和meta各一篇，都因为栏目不合适被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=5, topicName=null, topicId=null, topicList=[TopicDto(id=84506, encryptionId=3b1484506af, topicName=脊柱)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/ffbd7ae7f19a46d4bc76eadb164c5760/b3d082253d45492c9aa02bec640eb0af.jpg, createdBy=52185311019, createdName=drbob, createdTime=Fri Jul 03 11:54:53 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947860, encodeId=624594e86084, content=骨科专科杂志，最新IF=2.854，收录范围：骨科、康复、整形外科、运动医学、骨科临床手术或与骨科相关的基础研究等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sat Mar 13 14:39:53 CST 2021, time=2021-03-13, status=1, ipAttribution=)]

2022-03-10 ms4000000490604277

杂志让我大修，但是我没有看到审稿人的意见，请问在哪里可以找到审稿人的意见。谢谢！

61 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=854014, encodeId=5dcc8540144c, content=该期刊要求的参考文献格式是endnote中的那种格式形式？？？？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Sat Sep 28 20:17:08 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201158, encodeId=f44c120115812, content=杂志让我大修，但是我没有看到审稿人的意见，请问在哪里可以找到审稿人的意见。谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9535709916, createdName=ms4000000490604277, createdTime=Thu Mar 10 09:26:53 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092120, encodeId=20af109212061, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558103, encodeId=21b25581031e, content=4月27日submit 6月3日minor revision 6月19日final decision accept 挺快的，哪位老师知道，我什么时候才能收到proof的连接？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OUyyGOPy0mM0ibLLxiccOYeFdnmeZ4e2wHZzhia9yQGb1NalRFoQdokXjW9EOd5EEKyBxDibrfOgmA6uibTvE937MPA/132, createdBy=9c5c1768279, createdName=老时, createdTime=Tue Jun 19 19:21:00 CST 2018, time=2018-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555066, encodeId=a3155550668c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：D+0 new submission, D+2 editor assigned, D+32 revise before review(要求加2 reference), D+32 revision submission, D+36 reviewers assigned, D+38 under review, D+43 reviewers assigned, D+45 reviewers assigned , D+76 直接accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92ec2265994, createdName=Midaniel, createdTime=Mon Apr 16 21:49:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601798, encodeId=ea04601e9857, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿到一审结束一个月，大修后录用，对创新性要求比较高，最好对临床有一定指导意义的文章容易录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b78f1736747, createdName=南方一刀, createdTime=Mon Jun 08 13:24:15 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092119, encodeId=34a3109211961, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965334, encodeId=549296533478, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨科临床研究 ; 骨科 经验分享：投稿半个月，目前已经接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e165222307, createdName=147818b7m56暂无昵称, createdTime=Thu May 13 21:30:24 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801061, encodeId=493180106181, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：sicot的官方杂志，2019的if也是猛涨，但是命中率狠低，但是审稿速度很快，可以尝试!<a href='/topic/show?id=3b1484506af' target=_blank style='color:#2F92EE;'>#脊柱#</a>但是对脊柱的文章需求量很少，真的真的太难中了，投了腰椎的和meta各一篇，都因为栏目不合适被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=5, topicName=null, topicId=null, topicList=[TopicDto(id=84506, encryptionId=3b1484506af, topicName=脊柱)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/ffbd7ae7f19a46d4bc76eadb164c5760/b3d082253d45492c9aa02bec640eb0af.jpg, createdBy=52185311019, createdName=drbob, createdTime=Fri Jul 03 11:54:53 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947860, encodeId=624594e86084, content=骨科专科杂志，最新IF=2.854，收录范围：骨科、康复、整形外科、运动医学、骨科临床手术或与骨科相关的基础研究等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sat Mar 13 14:39:53 CST 2021, time=2021-03-13, status=1, ipAttribution=)]

2021-12-29 学医的彭于晏

什么是SCI？

57 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=854014, encodeId=5dcc8540144c, content=该期刊要求的参考文献格式是endnote中的那种格式形式？？？？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Sat Sep 28 20:17:08 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201158, encodeId=f44c120115812, content=杂志让我大修，但是我没有看到审稿人的意见，请问在哪里可以找到审稿人的意见。谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9535709916, createdName=ms4000000490604277, createdTime=Thu Mar 10 09:26:53 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092120, encodeId=20af109212061, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558103, encodeId=21b25581031e, content=4月27日submit 6月3日minor revision 6月19日final decision accept 挺快的，哪位老师知道，我什么时候才能收到proof的连接？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OUyyGOPy0mM0ibLLxiccOYeFdnmeZ4e2wHZzhia9yQGb1NalRFoQdokXjW9EOd5EEKyBxDibrfOgmA6uibTvE937MPA/132, createdBy=9c5c1768279, createdName=老时, createdTime=Tue Jun 19 19:21:00 CST 2018, time=2018-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555066, encodeId=a3155550668c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：D+0 new submission, D+2 editor assigned, D+32 revise before review(要求加2 reference), D+32 revision submission, D+36 reviewers assigned, D+38 under review, D+43 reviewers assigned, D+45 reviewers assigned , D+76 直接accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92ec2265994, createdName=Midaniel, createdTime=Mon Apr 16 21:49:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601798, encodeId=ea04601e9857, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿到一审结束一个月，大修后录用，对创新性要求比较高，最好对临床有一定指导意义的文章容易录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b78f1736747, createdName=南方一刀, createdTime=Mon Jun 08 13:24:15 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092119, encodeId=34a3109211961, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965334, encodeId=549296533478, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨科临床研究 ; 骨科 经验分享：投稿半个月，目前已经接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e165222307, createdName=147818b7m56暂无昵称, createdTime=Thu May 13 21:30:24 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801061, encodeId=493180106181, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：sicot的官方杂志，2019的if也是猛涨，但是命中率狠低，但是审稿速度很快，可以尝试!<a href='/topic/show?id=3b1484506af' target=_blank style='color:#2F92EE;'>#脊柱#</a>但是对脊柱的文章需求量很少，真的真的太难中了，投了腰椎的和meta各一篇，都因为栏目不合适被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=5, topicName=null, topicId=null, topicList=[TopicDto(id=84506, encryptionId=3b1484506af, topicName=脊柱)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/ffbd7ae7f19a46d4bc76eadb164c5760/b3d082253d45492c9aa02bec640eb0af.jpg, createdBy=52185311019, createdName=drbob, createdTime=Fri Jul 03 11:54:53 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947860, encodeId=624594e86084, content=骨科专科杂志，最新IF=2.854，收录范围：骨科、康复、整形外科、运动医学、骨科临床手术或与骨科相关的基础研究等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sat Mar 13 14:39:53 CST 2021, time=2021-03-13, status=1, ipAttribution=)]

2018-06-19 老时

4月27日submit
6月3日minor revision
6月19日final decision accept
挺快的，哪位老师知道，我什么时候才能收到proof的连接？

262 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=854014, encodeId=5dcc8540144c, content=该期刊要求的参考文献格式是endnote中的那种格式形式？？？？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Sat Sep 28 20:17:08 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201158, encodeId=f44c120115812, content=杂志让我大修，但是我没有看到审稿人的意见，请问在哪里可以找到审稿人的意见。谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9535709916, createdName=ms4000000490604277, createdTime=Thu Mar 10 09:26:53 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092120, encodeId=20af109212061, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558103, encodeId=21b25581031e, content=4月27日submit 6月3日minor revision 6月19日final decision accept 挺快的，哪位老师知道，我什么时候才能收到proof的连接？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OUyyGOPy0mM0ibLLxiccOYeFdnmeZ4e2wHZzhia9yQGb1NalRFoQdokXjW9EOd5EEKyBxDibrfOgmA6uibTvE937MPA/132, createdBy=9c5c1768279, createdName=老时, createdTime=Tue Jun 19 19:21:00 CST 2018, time=2018-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555066, encodeId=a3155550668c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：D+0 new submission, D+2 editor assigned, D+32 revise before review(要求加2 reference), D+32 revision submission, D+36 reviewers assigned, D+38 under review, D+43 reviewers assigned, D+45 reviewers assigned , D+76 直接accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92ec2265994, createdName=Midaniel, createdTime=Mon Apr 16 21:49:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601798, encodeId=ea04601e9857, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿到一审结束一个月，大修后录用，对创新性要求比较高，最好对临床有一定指导意义的文章容易录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b78f1736747, createdName=南方一刀, createdTime=Mon Jun 08 13:24:15 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092119, encodeId=34a3109211961, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965334, encodeId=549296533478, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨科临床研究 ; 骨科 经验分享：投稿半个月，目前已经接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e165222307, createdName=147818b7m56暂无昵称, createdTime=Thu May 13 21:30:24 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801061, encodeId=493180106181, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：sicot的官方杂志，2019的if也是猛涨，但是命中率狠低，但是审稿速度很快，可以尝试!<a href='/topic/show?id=3b1484506af' target=_blank style='color:#2F92EE;'>#脊柱#</a>但是对脊柱的文章需求量很少，真的真的太难中了，投了腰椎的和meta各一篇，都因为栏目不合适被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=5, topicName=null, topicId=null, topicList=[TopicDto(id=84506, encryptionId=3b1484506af, topicName=脊柱)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/ffbd7ae7f19a46d4bc76eadb164c5760/b3d082253d45492c9aa02bec640eb0af.jpg, createdBy=52185311019, createdName=drbob, createdTime=Fri Jul 03 11:54:53 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947860, encodeId=624594e86084, content=骨科专科杂志，最新IF=2.854，收录范围：骨科、康复、整形外科、运动医学、骨科临床手术或与骨科相关的基础研究等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sat Mar 13 14:39:53 CST 2021, time=2021-03-13, status=1, ipAttribution=)]

2018-04-16 Midaniel

审稿速度:3.0 | 投稿命中率:50.0
经验分享：D+0 new submission, D+2 editor assigned, D+32 revise before review(要求加2 reference), D+32 revision submission, D+36 reviewers assigned, D+38 under review, D+43 reviewers assigned, D+45 reviewers assigned , D+76 直接accept!

277 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=854014, encodeId=5dcc8540144c, content=该期刊要求的参考文献格式是endnote中的那种格式形式？？？？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Sat Sep 28 20:17:08 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201158, encodeId=f44c120115812, content=杂志让我大修，但是我没有看到审稿人的意见，请问在哪里可以找到审稿人的意见。谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9535709916, createdName=ms4000000490604277, createdTime=Thu Mar 10 09:26:53 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092120, encodeId=20af109212061, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558103, encodeId=21b25581031e, content=4月27日submit 6月3日minor revision 6月19日final decision accept 挺快的，哪位老师知道，我什么时候才能收到proof的连接？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OUyyGOPy0mM0ibLLxiccOYeFdnmeZ4e2wHZzhia9yQGb1NalRFoQdokXjW9EOd5EEKyBxDibrfOgmA6uibTvE937MPA/132, createdBy=9c5c1768279, createdName=老时, createdTime=Tue Jun 19 19:21:00 CST 2018, time=2018-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555066, encodeId=a3155550668c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：D+0 new submission, D+2 editor assigned, D+32 revise before review(要求加2 reference), D+32 revision submission, D+36 reviewers assigned, D+38 under review, D+43 reviewers assigned, D+45 reviewers assigned , D+76 直接accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92ec2265994, createdName=Midaniel, createdTime=Mon Apr 16 21:49:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601798, encodeId=ea04601e9857, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿到一审结束一个月，大修后录用，对创新性要求比较高，最好对临床有一定指导意义的文章容易录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b78f1736747, createdName=南方一刀, createdTime=Mon Jun 08 13:24:15 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092119, encodeId=34a3109211961, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965334, encodeId=549296533478, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨科临床研究 ; 骨科 经验分享：投稿半个月，目前已经接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e165222307, createdName=147818b7m56暂无昵称, createdTime=Thu May 13 21:30:24 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801061, encodeId=493180106181, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：sicot的官方杂志，2019的if也是猛涨，但是命中率狠低，但是审稿速度很快，可以尝试!<a href='/topic/show?id=3b1484506af' target=_blank style='color:#2F92EE;'>#脊柱#</a>但是对脊柱的文章需求量很少，真的真的太难中了，投了腰椎的和meta各一篇，都因为栏目不合适被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=5, topicName=null, topicId=null, topicList=[TopicDto(id=84506, encryptionId=3b1484506af, topicName=脊柱)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/ffbd7ae7f19a46d4bc76eadb164c5760/b3d082253d45492c9aa02bec640eb0af.jpg, createdBy=52185311019, createdName=drbob, createdTime=Fri Jul 03 11:54:53 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947860, encodeId=624594e86084, content=骨科专科杂志，最新IF=2.854，收录范围：骨科、康复、整形外科、运动医学、骨科临床手术或与骨科相关的基础研究等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sat Mar 13 14:39:53 CST 2021, time=2021-03-13, status=1, ipAttribution=)]

2020-06-08 南方一刀

审稿速度:2.0 | 投稿命中率:25.0
经验分享：投稿到一审结束一个月，大修后录用，对创新性要求比较高，最好对临床有一定指导意义的文章容易录用

130 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=854014, encodeId=5dcc8540144c, content=该期刊要求的参考文献格式是endnote中的那种格式形式？？？？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Sat Sep 28 20:17:08 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201158, encodeId=f44c120115812, content=杂志让我大修，但是我没有看到审稿人的意见，请问在哪里可以找到审稿人的意见。谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9535709916, createdName=ms4000000490604277, createdTime=Thu Mar 10 09:26:53 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092120, encodeId=20af109212061, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558103, encodeId=21b25581031e, content=4月27日submit 6月3日minor revision 6月19日final decision accept 挺快的，哪位老师知道，我什么时候才能收到proof的连接？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OUyyGOPy0mM0ibLLxiccOYeFdnmeZ4e2wHZzhia9yQGb1NalRFoQdokXjW9EOd5EEKyBxDibrfOgmA6uibTvE937MPA/132, createdBy=9c5c1768279, createdName=老时, createdTime=Tue Jun 19 19:21:00 CST 2018, time=2018-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555066, encodeId=a3155550668c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：D+0 new submission, D+2 editor assigned, D+32 revise before review(要求加2 reference), D+32 revision submission, D+36 reviewers assigned, D+38 under review, D+43 reviewers assigned, D+45 reviewers assigned , D+76 直接accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92ec2265994, createdName=Midaniel, createdTime=Mon Apr 16 21:49:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601798, encodeId=ea04601e9857, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿到一审结束一个月，大修后录用，对创新性要求比较高，最好对临床有一定指导意义的文章容易录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b78f1736747, createdName=南方一刀, createdTime=Mon Jun 08 13:24:15 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092119, encodeId=34a3109211961, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965334, encodeId=549296533478, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨科临床研究 ; 骨科 经验分享：投稿半个月，目前已经接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e165222307, createdName=147818b7m56暂无昵称, createdTime=Thu May 13 21:30:24 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801061, encodeId=493180106181, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：sicot的官方杂志，2019的if也是猛涨，但是命中率狠低，但是审稿速度很快，可以尝试!<a href='/topic/show?id=3b1484506af' target=_blank style='color:#2F92EE;'>#脊柱#</a>但是对脊柱的文章需求量很少，真的真的太难中了，投了腰椎的和meta各一篇，都因为栏目不合适被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=5, topicName=null, topicId=null, topicList=[TopicDto(id=84506, encryptionId=3b1484506af, topicName=脊柱)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/ffbd7ae7f19a46d4bc76eadb164c5760/b3d082253d45492c9aa02bec640eb0af.jpg, createdBy=52185311019, createdName=drbob, createdTime=Fri Jul 03 11:54:53 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947860, encodeId=624594e86084, content=骨科专科杂志，最新IF=2.854，收录范围：骨科、康复、整形外科、运动医学、骨科临床手术或与骨科相关的基础研究等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sat Mar 13 14:39:53 CST 2021, time=2021-03-13, status=1, ipAttribution=)]

2021-12-29 Gym璨烨

如果文章发表了未提供ORCIDID如何添加？

40 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=854014, encodeId=5dcc8540144c, content=该期刊要求的参考文献格式是endnote中的那种格式形式？？？？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Sat Sep 28 20:17:08 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201158, encodeId=f44c120115812, content=杂志让我大修，但是我没有看到审稿人的意见，请问在哪里可以找到审稿人的意见。谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9535709916, createdName=ms4000000490604277, createdTime=Thu Mar 10 09:26:53 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092120, encodeId=20af109212061, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558103, encodeId=21b25581031e, content=4月27日submit 6月3日minor revision 6月19日final decision accept 挺快的，哪位老师知道，我什么时候才能收到proof的连接？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OUyyGOPy0mM0ibLLxiccOYeFdnmeZ4e2wHZzhia9yQGb1NalRFoQdokXjW9EOd5EEKyBxDibrfOgmA6uibTvE937MPA/132, createdBy=9c5c1768279, createdName=老时, createdTime=Tue Jun 19 19:21:00 CST 2018, time=2018-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555066, encodeId=a3155550668c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：D+0 new submission, D+2 editor assigned, D+32 revise before review(要求加2 reference), D+32 revision submission, D+36 reviewers assigned, D+38 under review, D+43 reviewers assigned, D+45 reviewers assigned , D+76 直接accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92ec2265994, createdName=Midaniel, createdTime=Mon Apr 16 21:49:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601798, encodeId=ea04601e9857, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿到一审结束一个月，大修后录用，对创新性要求比较高，最好对临床有一定指导意义的文章容易录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b78f1736747, createdName=南方一刀, createdTime=Mon Jun 08 13:24:15 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092119, encodeId=34a3109211961, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965334, encodeId=549296533478, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨科临床研究 ; 骨科 经验分享：投稿半个月，目前已经接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e165222307, createdName=147818b7m56暂无昵称, createdTime=Thu May 13 21:30:24 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801061, encodeId=493180106181, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：sicot的官方杂志，2019的if也是猛涨，但是命中率狠低，但是审稿速度很快，可以尝试!<a href='/topic/show?id=3b1484506af' target=_blank style='color:#2F92EE;'>#脊柱#</a>但是对脊柱的文章需求量很少，真的真的太难中了，投了腰椎的和meta各一篇，都因为栏目不合适被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=5, topicName=null, topicId=null, topicList=[TopicDto(id=84506, encryptionId=3b1484506af, topicName=脊柱)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/ffbd7ae7f19a46d4bc76eadb164c5760/b3d082253d45492c9aa02bec640eb0af.jpg, createdBy=52185311019, createdName=drbob, createdTime=Fri Jul 03 11:54:53 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947860, encodeId=624594e86084, content=骨科专科杂志，最新IF=2.854，收录范围：骨科、康复、整形外科、运动医学、骨科临床手术或与骨科相关的基础研究等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sat Mar 13 14:39:53 CST 2021, time=2021-03-13, status=1, ipAttribution=)]

2021-05-13 147818b7m56暂无昵称

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：骨科临床研究 ; 骨科
经验分享：投稿半个月，目前已经接收

0 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=854014, encodeId=5dcc8540144c, content=该期刊要求的参考文献格式是endnote中的那种格式形式？？？？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Sat Sep 28 20:17:08 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201158, encodeId=f44c120115812, content=杂志让我大修，但是我没有看到审稿人的意见，请问在哪里可以找到审稿人的意见。谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9535709916, createdName=ms4000000490604277, createdTime=Thu Mar 10 09:26:53 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092120, encodeId=20af109212061, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558103, encodeId=21b25581031e, content=4月27日submit 6月3日minor revision 6月19日final decision accept 挺快的，哪位老师知道，我什么时候才能收到proof的连接？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OUyyGOPy0mM0ibLLxiccOYeFdnmeZ4e2wHZzhia9yQGb1NalRFoQdokXjW9EOd5EEKyBxDibrfOgmA6uibTvE937MPA/132, createdBy=9c5c1768279, createdName=老时, createdTime=Tue Jun 19 19:21:00 CST 2018, time=2018-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555066, encodeId=a3155550668c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：D+0 new submission, D+2 editor assigned, D+32 revise before review(要求加2 reference), D+32 revision submission, D+36 reviewers assigned, D+38 under review, D+43 reviewers assigned, D+45 reviewers assigned , D+76 直接accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92ec2265994, createdName=Midaniel, createdTime=Mon Apr 16 21:49:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601798, encodeId=ea04601e9857, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿到一审结束一个月，大修后录用，对创新性要求比较高，最好对临床有一定指导意义的文章容易录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b78f1736747, createdName=南方一刀, createdTime=Mon Jun 08 13:24:15 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092119, encodeId=34a3109211961, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965334, encodeId=549296533478, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨科临床研究 ; 骨科 经验分享：投稿半个月，目前已经接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e165222307, createdName=147818b7m56暂无昵称, createdTime=Thu May 13 21:30:24 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801061, encodeId=493180106181, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：sicot的官方杂志，2019的if也是猛涨，但是命中率狠低，但是审稿速度很快，可以尝试!<a href='/topic/show?id=3b1484506af' target=_blank style='color:#2F92EE;'>#脊柱#</a>但是对脊柱的文章需求量很少，真的真的太难中了，投了腰椎的和meta各一篇，都因为栏目不合适被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=5, topicName=null, topicId=null, topicList=[TopicDto(id=84506, encryptionId=3b1484506af, topicName=脊柱)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/ffbd7ae7f19a46d4bc76eadb164c5760/b3d082253d45492c9aa02bec640eb0af.jpg, createdBy=52185311019, createdName=drbob, createdTime=Fri Jul 03 11:54:53 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947860, encodeId=624594e86084, content=骨科专科杂志，最新IF=2.854，收录范围：骨科、康复、整形外科、运动医学、骨科临床手术或与骨科相关的基础研究等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sat Mar 13 14:39:53 CST 2021, time=2021-03-13, status=1, ipAttribution=)]

2020-07-03 drbob

审稿速度:1.0 | 投稿命中率:25.0
经验分享：sicot的官方杂志，2019的if也是猛涨，但是命中率狠低，但是审稿速度很快，可以尝试!#脊柱#但是对脊柱的文章需求量很少，真的真的太难中了，投了腰椎的和meta各一篇，都因为栏目不合适被拒

4 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=854014, encodeId=5dcc8540144c, content=该期刊要求的参考文献格式是endnote中的那种格式形式？？？？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8ec15413992, createdName=ms9495958415321966, createdTime=Sat Sep 28 20:17:08 CST 2019, time=2019-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201158, encodeId=f44c120115812, content=杂志让我大修，但是我没有看到审稿人的意见，请问在哪里可以找到审稿人的意见。谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9535709916, createdName=ms4000000490604277, createdTime=Thu Mar 10 09:26:53 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092120, encodeId=20af109212061, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558103, encodeId=21b25581031e, content=4月27日submit 6月3日minor revision 6月19日final decision accept 挺快的，哪位老师知道，我什么时候才能收到proof的连接？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OUyyGOPy0mM0ibLLxiccOYeFdnmeZ4e2wHZzhia9yQGb1NalRFoQdokXjW9EOd5EEKyBxDibrfOgmA6uibTvE937MPA/132, createdBy=9c5c1768279, createdName=老时, createdTime=Tue Jun 19 19:21:00 CST 2018, time=2018-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555066, encodeId=a3155550668c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：D+0 new submission, D+2 editor assigned, D+32 revise before review(要求加2 reference), D+32 revision submission, D+36 reviewers assigned, D+38 under review, D+43 reviewers assigned, D+45 reviewers assigned , D+76 直接accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92ec2265994, createdName=Midaniel, createdTime=Mon Apr 16 21:49:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601798, encodeId=ea04601e9857, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿到一审结束一个月，大修后录用，对创新性要求比较高，最好对临床有一定指导意义的文章容易录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b78f1736747, createdName=南方一刀, createdTime=Mon Jun 08 13:24:15 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092119, encodeId=34a3109211961, content=如果文章发表了未提供ORCIDID如何添加？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965334, encodeId=549296533478, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨科临床研究 ; 骨科 经验分享：投稿半个月，目前已经接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e165222307, createdName=147818b7m56暂无昵称, createdTime=Thu May 13 21:30:24 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801061, encodeId=493180106181, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：sicot的官方杂志，2019的if也是猛涨，但是命中率狠低，但是审稿速度很快，可以尝试!<a href='/topic/show?id=3b1484506af' target=_blank style='color:#2F92EE;'>#脊柱#</a>但是对脊柱的文章需求量很少，真的真的太难中了，投了腰椎的和meta各一篇，都因为栏目不合适被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=5, topicName=null, topicId=null, topicList=[TopicDto(id=84506, encryptionId=3b1484506af, topicName=脊柱)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/ffbd7ae7f19a46d4bc76eadb164c5760/b3d082253d45492c9aa02bec640eb0af.jpg, createdBy=52185311019, createdName=drbob, createdTime=Fri Jul 03 11:54:53 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947860, encodeId=624594e86084, content=骨科专科杂志，最新IF=2.854，收录范围：骨科、康复、整形外科、运动医学、骨科临床手术或与骨科相关的基础研究等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=小小医者, createdTime=Sat Mar 13 14:39:53 CST 2021, time=2021-03-13, status=1, ipAttribution=)]

2021-03-13 小小医者

骨科专科杂志，最新IF=2.854，收录范围：骨科、康复、整形外科、运动医学、骨科临床手术或与骨科相关的基础研究等。

65 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务